```json
{
  "entities": [
    {
      "type": "Microbe",
      "name": "Escherichia coli"
    },
    {
      "type": "Microbe",
      "name": "BCL-XL-1/2"
    },
    {
      "type": "Physiological trait",
      "name": "amyloidogenic"
    },
    {
      "type": "Physiological trait",
      "name": "aggregation-prone"
    },
    {
      "type": "Physiological trait",
      "name": "solubilize"
    },
    {
      "type": "Physiological trait",
      "name": "low yields"
    },
    {
      "type": "Physiological trait",
      "name": "difficult optimizations"
    },
      {
      "type": "Physiological trait",
      "name": "isolation challenges"
    },
    {
      "type": "Physiological trait",
      "name": "minimizes toxicity"
    },
    {
      "type": "Morphological trait",
      "name": "inclusion bodies"
    },
    {
      "type": "Physiological trait",
      "name": "denaturing solutions"
    },
    {
      "type": "Physiological trait",
      "name": "immobilized metal affinity chromatography"
    },
    {
      "type": "Physiological trait",
      "name": "reverse phase HPLC"
    },
    {
      "type": "Physiological trait",
      "name": "cyanogen bromide cleavage"
    },
    {
      "type": "Physiological trait",
      "name": "milligram quantities"
    },
    {
      "type": "Physiological trait",
      "name": "isotopically label"
    },
    {
      "type": "Habitat",
      "name": "bacterial inclusion bodies"
    }
  ],
  "relationships": [
    {
      "type": "Exhibits",
      "source": "amyloidogenic peptides",
      "target": "aggregation-prone"
    },
    {
      "type": "Exhibits",
      "source": "expression systems",
      "target": "low yields"
    },
    {
      "type": "Exhibits",
      "source": "expression systems",
      "target": "difficult optimizations"
    },
    {
      "type": "Exhibits",
      "source": "expression systems",
      "target": "isolation challenges"
    },
    {
      "type": "Exhibits",
      "source": "BCL-XL-1/2",
      "target": "drives the expression into bacterial inclusion bodies"
    },
    {
      "type": "Exhibits",
      "source": "BCL-XL-1/2",
      "target": "minimizes toxicity"
    },
    {
      "type": "Isolated from",
      "source": "amyloidogenic peptides",
      "target": "bacterial inclusion bodies"
    },
    {
      "type": "Exhibits",
      "source": "immobilized metal affinity chromatography",
      "target": "isolate the peptide"
    },
    {
      "type": "Exhibits",
      "source": "reverse phase HPLC",
      "target": "isolate the peptide"
    },
    {
      "type": "Exhibits",
      "source": "cyanogen bromide cleavage",
      "target": "isolate the peptide"
    },
    {
      "type": "Exhibits",
      "source": "reverse phase HPLC",
      "target": "yields milligram quantities"
    },
    {
      "type": "Exhibits",
      "source": "fusion to BCL-XL-1/2",
      "target": "general strategy"
    },
    {
      "type": "Exhibits",
      "source": "Escherichia coli",
      "target": "expression of amyloidogenic peptides"
    }
  ]
}
```